Uncover the Robust Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products

In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety of gene therapy products

Whether you're looking for specific characterisation, potency or infectivity approaches to improve your current analytical toolbox or if you're seeking to understand how gene therapy analytics differ from other biologics you've worked on in the past, this focused, technical event will provide insights specifically on the unique analytical challenges posed by gene therapy vectors, delivered by 'boots on the ground' scientists grappling with these challenges first-hand.

Join 150+ analytical pioneers to discover the realities of working with tools like dPCR, AUC and HPLC, as well as how and where these tools can be most effective in process development, and what the European regulators expect in order to grant approval. Whether you're working with AAV or lentiviral vectors, this is your opportunity to enhance your existing analytical methods and explore innovative new tools to support safe and effective gene therapy development.

Access the 2022 full event guide to see what you missed.

2022 Top Expert Speakers

Axel Ståhlbom

Current Member

EDQM Gene Therapy Products working party

Sol Ruiz

Head of Biologics, Biotechnology, and Advanced Therapies

Spanish Medicines Agency (AEMPS)

Paul Devine

Senior Scientist


Bernd Innthaler

Lead Separation Methods, Gene Therapy Process Development


Simon Briggs

Head of Gene Therapy Technical Product Development


Steven Wolk

Vice President, Analytical Chemistry & Site Head Boulder


Ilya Shestopalov

Director and Analytical, Product Lead

bluebird bio

Dr. Lutz Ehrhardt

Senior Manager Field Marketing Centrifugation Europe

Beckman Coulter Life Sciences

Other Events in the Gene Therapy Series